The DOI matches its Crossref record; 21 of the 25 references it cites were found in a registry or an index; 22 of the 28 sources its claims cite were checked for support.
Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation?
Open accessAbstract
Background: Human herpesvirus 6 (HHV-6) is considered a ubiquitous virus, with many countries reporting a seroprevalence of more than 80–90% among the general population. However, this virus is unique among herpesviruses in its ability to integrate into the genetic material of the host’s cells. Thus, there are three ways by which HHV-6 can cause an active infection–primary infection, reactivation of a latent acquired infection, or activation of iciHHV-6 (inherited chromosomally integrated HHV-6). Whole blood quantitative polymerase chain reaction (qPCR) is very useful in distinguishing between iciHHV-6 and primary infection/reactivation. Our aim is to assess the role of HHV-6 in the aetiology of central nervous system (CNS) infections in adults and children, to describe all HHV-6-positive cases in an attempt to determine the susceptible population and to identify potential risk factors that can be linked to HHV-6 meningoencephalitis. Methods: We performed a retrospective study involving patients that were admitted to Prof. Dr. Matei Bals National Institute of Infectious Diseases, Bucharest, Romania, with a diagnosis of meningitis or encephalitis. We only selected the clinical records of patients that had a multiplex PCR Biofire® FilmArray® meningitis/encephalitis panel. Results: We report a 5% HHV-6 positivity in the cerebrospinal fluid (CSF) of patients with CNS infections tested with a commercial multiplex PCR M/E (meningitis/encephalitis) panel. Additionally, 2% to 4% of the total study population (n = 100) had active HHV-6 infections, which denotes 40 to 80% of the HHV-6-positive samples. We did not observe any statistically significant correlation between HHV-6 positivity in the CSF and variables such as age, sex, or comorbidities, including obesity, diabetes, hypertension, immunosuppression, or oncologic disease. Therefore, no risk factors could be linked with HHV-6 positivity in the CSF. Conclusions: although multiplex qualitative PCR is highly useful for providing rapid results and identifying nearly every pathogen that can cause meningitis/encephalitis, we have to be aware of this type of test’s limitations. All patients with HHV-6 detectable in their CSF via a multiplex PCR test should also undergo qPCR testing from both CSF and blood to prevent over-diagnosing HHV-6 CNS infections, to avoid unnecessary antiviral treatments, and ensure the accurate identification of the true diagnosis.
Overview
CoChat Summary
TL;DR
This retrospective single-center study of 100 meningitis/encephalitis patients found HHV-6 DNA in CSF in 5% of cases, but only 2%–4% were judged to represent active HHV-6 CNS infection after considering blood/CSF qPCR and clinical context. The authors argue that multiplex qualitative PCR alone can overcall HHV-6 CNS disease and that paired CSF and blood qPCR is needed to distinguish active infection from iciHHV-6 or reactivation.
Key findings
- Among 100 patients tested with a multiplex CSF panel, 5/100 (5%) had HHV-6 detectable in CSF; 2/19 pediatric patients (10%) and 3/81 adults (2.43% of adults) were HHV-6-positive.
- The study reports 2%–4% of the total sample (2/100 to 4/100) had active HHV-6 infection, corresponding to 40%–80% of HHV-6-positive CSF samples.
- No statistically significant correlation was found between HHV-6 CSF positivity and age, sex, obesity, diabetes, hypertension, immunosuppression, or oncologic disease.
- Of the 5 HHV-6-positive cases, 2 pediatric cases were interpreted as primary infection, 1 adult case as HHV-6 reactivation with Listeria monocytogenes meningitis, 1 as likely bacterial nosocomial meningitis with uncertain HHV-6 role, and 1 as possible HHV-6-triggered Rasmussen encephalitis in a patient with HIV but normal CD4 count and undetectable HIV RNA.
Methods
- Retrospective study at Prof. Dr. Matei Bals National Institute of Infectious Diseases (Bucharest, Romania), including patients admitted with meningitis or encephalitis between 1 January 2022 and 30 May 2023.
- Included only patients who had CSF multiplex PCR (Biofire FilmArray meningitis/encephalitis panel); after exclusions, the analyzed sample was 100 patients.
- Collected clinical records data on demographics, symptoms, comorbidities, labs, CSF parameters, cultures, treatment, and performed qualitative multiplex PCR, with qPCR from blood and/or CSF in selected cases; associations were tested with chi-square/non-parametric analyses in SPSS v26.
Limitations
- The authors state the study was retrospective, which prevented qPCR testing on all HHV-6-positive CSF cases and left uncertainty in at least one case about iciHHV-6 versus reactivation.
- The sample was small and single-center, which the authors note may help explain differences from prior studies.
- Evident from the text: conclusions about “active HHV-6” rest on only 2 cases with paired qPCR from blood and CSF, so case classification is limited by incomplete molecular confirmation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
7 Valid · 5 Not valid · 3 Not checked · 50 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Whole blood quantitative polymerase chain reaction (qPCR) is very useful in distinguishing between iciHHV-6 and primary infection/reactivation.”
§ Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? > Abstract Background: Human herpesvirus 6 (HHV-6) is considered a ubiquitous virus, with many countries reporting a seroprevalence of more than 80–90% among the general population. However, this virus is unique among herpesviruses in its ability to integrate into the genetic material of the host’s cells. Thus, there are three ways by which HHV-6 can cause an active infection–primary infection, reactivation of a latent acquired infection, or activation of iciHHV-6 (inherited chromosomally integrated HHV-6). Whole blood quantitative polymerase chain reaction (qPCR) is very useful in distinguishing between iciHHV-6 and primary infection/reactivation. Our aim is to assess the role of HHV-6 in the aetiology of central nervous system (CNS) infections in adults and children, to describe all HHV-6-positive cases in an attempt to determine the susceptible population and to identify potential risk factors that can be linked to HHV-6 meningoencephalitis. Methods: We performed a retrospective study involving patients that were admitted to Prof. Dr. Matei Bals National Institute of Infectious Diseases, Bucharest, Romania, with a diagnosis of meningitis or encephalitis. We only selected the clinical records of patients that had a multiplex PCR Biofire® FilmArray® meningitis/encephalitis panel. Results: We report a 5% HHV-6 positivity in the cerebrospinal fluid (CSF) of patients with CNS infections tested with a commercial multiplex PCR M/E (meningitis/encephalitis) panel. Additionally, 2% to 4% of the total study population (n = 100) had active HHV-6 infections, which denotes 40 to 80% of the HHV-6-positive samples. We did not observe any statistically significant correlation between HHV-6 positivity in the CSF and variables such as age, sex, or comorbidities, including obesity, diabetes, hypertension, immunosuppression, or oncologic disease. Therefore, no risk factors could be linked with HHV-6 positivity in the CSF. Conclusions: although multiplex qualitative PCR is highly useful for providing rapid results and identifying nearly every pathogen that can cause meningitis/encephalitis, we have to be aware of this type of test’s limitations. All patients with HHV-6 detectable in their CSF via a multiplex PCR test should also undergo qPCR testing from both CSF and blood to prevent over-diagnosing HHV-6 CNS infections, to avoid unnecessary antiviral treatments, and ensure the accurate identification of the true diagnosis.
What the sources say
- Supportedcites [10] Mekheal, 2022, A rare case of HHV-6 encephalitis in an immunocompetent host: Case report and literature review, Cureus source
The Discussion states that whole-blood PCR helps distinguish ciHHV-6 from actively replicating infection because viral loads in ciHHV-6 routinely exceed 1 million copies/mL. The paper did not perform whole-blood PCR in its own patient, but it explicitly supports the cited diagnostic use. (LLM, conf=0.92)
- Disputedcites [11] Valentini, 2023, HHV-6 Meningoencephalitis in a Healthy Adult Female, Case Rep. Emerg. Med. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) says PCR detection alone cannot distinguish active HHV-6 infection from persistent viral DNA caused by chromosomal integration. It does not discuss whole-blood qPCR specifically, but its stated limitation runs contrary to the claim that qPCR is very useful for making that distinction. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [12] Berzero, 2021, Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts, Neurol. Neuroimmunol. Neuroinflamm. sourceExperimental — accuracy not yet measured
The Alternative Diagnoses section reports much higher whole-blood HHV-6 viral loads in patients with chromosomally integrated HHV-6 than in comparison patients, so blood quantification can help raise suspicion. But the Methods section uses hair-follicle testing to identify chromosomal integration, and the Discussion emphasizes the CSF/blood replication ratio for diagnosis. The paper does not establish whole-blood qPCR alone as a reliable way to distinguish integration from both primary infection and reactivation. No page numbers were supplied for these passages. (LLM, conf=0.84)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Both paediatric patients were diagnosed with primary HHV-6 infection.”
§ Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? > 3. Results
What the sources say
- Disputedcites [14] Bhanushali, 2013, Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation, Neurology sourceExperimental — accuracy not yet measured
The Results report that all nine patients with HHV-6 encephalitis were aged 19–60 years, so the study had no paediatric patients. The Abstract describes HHV-6 reactivation after stem cell transplantation, not a diagnosis of primary infection in two children. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“This phenomenon is called inherited chromosomally integrated HHV-6 (iciHHV-6), and it is seen in almost 2% of the general population, meaning nearly 70 million people worldwide [7].”
- Also stated in: § 4. Discussion · boosted
“We know today that nearly 2% of the population has iciHHV-6 [7].”
§ Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? > 1. Introduction
What the sources say
- Could not verifycites [7] Baleguli, 2021, Human Herpesvirus 6 (HHV-6) Encephalitis in a Non-Transplant Patient with Polymyositis, Cureus sourceExperimental — accuracy not yet measured
The Introduction discusses HHV-6 infection and latency, and the References list a paper about chromosomally integrated HHV-6. Neither states how common inherited chromosomally integrated HHV-6 is. Searches for iciHHV-6, a 2% prevalence, and 70 million people found no supporting passage in our copy. (LLM, conf=0.76)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 4. Discussion · boosted
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In our study, of the 100 patients who had a meningitis/encephalitis panel performed, 5 had HHV-6 DNA detectable in their CSF (5%), which is consistent with what we found in the literature (ranging from 1.9% to 11.45%).”
§ Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? > 4. Discussion
What the sources say
- Partly supportedcites [19] Green, 2018, Clinical Significance of Human Herpesvirus 6 Positivity on the FilmArray Meningitis/Encephalitis Panel, Clin. Infect. Dis. sourceExperimental — accuracy not yet measured
The Results report HHV-6 detection in 15 of 793 patients tested with the ME panel (1.9%), supporting the lower end of the cited range. Our copy does not report an 11.45% positivity rate; the citing authors’ 5% figure is their own study result, not a finding attributed to this source. (LLM, conf=0.88)
- Could not verifycites [20] Ngo Nsoga, M.T., Pérez-Rodriguez, F.J., Mamin, A., L’Huillier, A.G., Cherkaoui, A., Kaiser, L., and Schibler, M. (2023). Rational Use of Microbiological Tests in the Diagnosis of Central Nervous System Infections Using Restrictive Criteria: A Retrospective Study. Microbiol. Spectr., 11. sourceExperimental — accuracy not yet measured
The Results report HHV-6 detections in this paper’s own CSF samples, but do not give a literature positivity range of 1.9%–11.45%. Searches for both percentages and for an HHV-6 positivity rate did not find that range in our copy; the citing authors’ 5% is their own finding, not a finding attributed to this source. (LLM, conf=0.76)
- Partly supportedcites [21] Pandey, 2020, Pathogen or Bystander: Clinical Significance of Detecting Human Herpesvirus 6 in Pediatric Cerebrospinal Fluid, J. Clin. Microbiol. sourceExperimental — accuracy not yet measured
The Results report HHV-6 DNA in 25 of 1,005 pediatric CSF samples (2.5%), supporting the comparison of the citing study’s 5% rate with a published rate. Our copy does not establish the stated literature range of 1.9% to 11.45%. (LLM, conf=0.85)
- Partly supportedcites [12] Berzero, 2021, Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts, Neurol. Neuroimmunol. Neuroinflamm. sourceExperimental — accuracy not yet measured
The Discussion reports HHV-6 DNA in the CSF of 43 of 926 tested patients (4.6%), which is close to the citing study’s 5%. It does not report the attributed literature range of 1.9%–11.45%; the citing study’s own 5-of-100 result is not a finding of this source. Page numbers were not available in our copy. (LLM, conf=0.88)
plainn = 100- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“HHV-6 was the aetiological agent of meningitis/meningoencephalitis in 20 to 36% of the cases [21].”
§ Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? > 4. Discussion
What the sources say
- Partly supportedcites [21] Pandey, 2020, Pathogen or Bystander: Clinical Significance of Detecting Human Herpesvirus 6 in Pediatric Cerebrospinal Fluid, J. Clin. Microbiol. sourceExperimental — accuracy not yet measured
The Results and Discussion report HHV-6 meningitis or meningoencephalitis in five of 25 HHV-6-positive pediatric patients (20%). They do not report 36% or a 20–36% range, so the upper end of the claimed range is unsupported. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
29 more claims · 1 with their cited sources checked
Create a free account to see all 65 claims and every source verdict.
- It may state two separate claims as one. 25
- Probably not a substantial claim. 9
Citations
Cites
Latent human herpesvirus 6 infection of human monocytes/macrophages
Kondo, K., Kondo, T., Okuno, T., Takahashi, M., & Yamanishi, K. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-6-1401 · Cited by 341 · cited 1×
“Under certain circumstances, usually immunosuppressive states, the virus can reactivate and exert a cytopathic effect [6].”
BackgroundHuman herpesvirus 6 latently infects early bone marrow progenitors in vivo
Luppi, M., Barozzi, P., Morris, C., Maiorana, A., Garber, R., Bonacorsi, G., Donelli, A., Marasca, R., Tabilio, A., & Torelli, G. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.754-759.1999 · Cited by 139
Human herpesvirus 6 infection in normal human brain tissue
Luppi, M., Barozzi, P., Maiorana, A., Marasca, R., & Torelli, G. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.4.943 · Cited by 130 · cited 1×
“Similar to all herpesviruses, HHV-6 causes a primary infection, usually during the first two-three years of life, after which it becomes dormant predominantly inside monocytes and macrophages [3–5].”
BackgroundGreen, D. A., Pereira, M., Miko, B., Radmard, S., Whittier, S., & Thakur, K. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy288 · Cited by 110
Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation
Bhanushali, M. J., Kranick, S. M., Freeman, A. F., Cuellar-Rodriguez, J. M., Battiwalla, M., Gea-Banacloche, J. C., Hickstein, D. D., Pavletic, S., Fahle, G., & Nath, A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828cf8a2 · Cited by 97 · cited 1×
“For the definition of meningoencephalitis caused by primary infection with HHV-6, we used the following criteria [14]: age 18 years with clinical features that are suggestive for meningoencephalitis, HHV-6 DNA detectable in the CSF, and the exclusion of other alternative diagnoses.”
MethodHuman herpesvirus 6 encephalitis in immunocompetent and immunocompromised hosts
Berzero, G., Campanini, G., Vegezzi, E., Paoletti, M., Pichiecchio, A., Simoncelli, A. M., Colombo, A. A., Bernasconi, P., Borsani, O., Di Matteo, A., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000942 · Cited by 76 · cited 2×
“Of these, nine patients had true CNS infections caused by HHV-6, which means 1.18% of the total study population and 24% of the patients were HHV-6-positive in their CSF [12].”
BackgroundMethodInfluentialClinical and laboratory features of human herpesvirus 6 chromosomal integration
Clark, D. A. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.12.022 · Cited by 75 · cited 1×
“People with iciHHV-6 have a 50% chance of passing on the integrated state of the virus to their offspring [8].”
BackgroundPandey, U., Greninger, A. L., Levin, G. R., Jerome, K. R., Anand, V. C., & Dien Bard, J. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00313-20 · Cited by 61 · cited 1×
“HHV-6 was the aetiological agent of meningitis/meningoencephalitis in 20 to 36% of the cases [21].”
BackgroundAndre-Garnier, E., Milpied, N., Boutolleau, D., Saiagh, S., Billaudel, S., & Imbert-Marcille, B.-M. (2004) · Journal of General Virology · doi:10.1099/vir.0.80319-0 · Cited by 27 · cited 1×
“Similar to all herpesviruses, HHV-6 causes a primary infection, usually during the first two-three years of life, after which it becomes dormant predominantly inside monocytes and macrophages [3–5].”
BackgroundAramă, V., Streinu‐Cercel, A., Vlădăreanu, R., et al. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.07.026 · Cited by 21 · cited 1×
“The only study that has assessed the seroprevalence of herpesviruses was published in 2010, and it only evaluated the seroprevalence of HSV-1 and HSV-2 [2].”
BackgroundSelf-citation
Cited by
Nicolau-Guillaumet, N., Moutel, M., Plouzeau-Jayle, C., Pean de Ponfilly, G., Courbin, V., Ranc, A.-G., Revillet, H., Mourvillier, B., Hentzien, M., Muggeo, A., et al. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00566-26 · Cited by 1
Congenital human herpesvirus 6 infection in a full-term newborn: literature review and case report
Карпова, А. Л., Мостовой, А. В., Baranov, A. A., Алексеевна, А. Л., Klubnichkina, E. V., Zaplatnikov, A. L., & Николаевич, К. Л. (2025) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2025.635 · Cited by 1
Taha, H. M., Zahran, A., Hajjeh, O., Abubaha, B., AbuBaha, M., & Marouf, O. (2026) · Clinical Case Reports · doi:10.1002/ccr3.73407
Aubry, A., Brochot, É., Demey, B., Louchet-Ducoroy, M., Pannier, C., Segard, C., François, C., & Castelain, S. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.108977
Cobos, D. F. O., Andrade, P. G. D., Cobos, A. O., & Villareal, D. K. L. (2026) · Atlas Research Journal · doi:10.65305/arj.v4n1.2026.69
Metadata
- Authors
- Ganea, O. A., Tilișcan, C., Streinu-Cercel, A., Pițigoi, D., Drăgănescu, A. C., Lazar, M., Mihai, N., Florea, D., Aramă, S. Ș., & Aramă, V.
- Affiliations
- Carol Davila University of Medicine and Pharmacy (RO)
- Faculty of General Medicine, Department of Infectious Diseases, “Carol Davila” University of Medicine and Pharmacy, Dionisie Lupu Street No. 37, 010458 Bucharest, Romania
- “Matei Bals” National Institute of Infectious Diseases, Dr. Calistrat Grozovici Street No. 1, 021105 Bucharest, Romania
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2024-08-08
- Volume
- 13
- Issue
- 16
- Pages
- 4660
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC11355476
- OpenAlex
- W4401416646
- Cited by
- 7
- References
- 25
- Citations by year
- 2026: 6 · 2025: 1
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of Medicine and Pharmacy Carol Davila
- Topics
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human herpesvirus 6, central nervous system infection, meningitis, encephalitis, immunocompetent patient, HHV-6 reactivation, BioFire FilmArray, cerebrospinal fluid, risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? https://app.cochat.ai/papers/10.3390/jcm13164660
- The paper
- Ganea, O. A., Tilișcan, C., Streinu-Cercel, A., Pițigoi, D., Drăgănescu, A. C., Lazar, M., Mihai, N., Florea, D., Aramă, S. Ș., & Aramă, V. (2024). Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? Journal of Clinical Medicine. https://doi.org/10.3390/jcm13164660
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

